Pneumonia remains a global health threat, in part due to expanding categories of susceptible 26 individuals and increasing prevalence of antibiotic resistant pathogens. However, therapeutic 42 resistance against bacterial pathogens and provide mechanistic insights into means to protect 43 vulnerable patients against lethal infections.
27
stimulation of the lungs' mucosal defenses by inhaled exposure to a synergistic combination of killing an estimated 2.7 million people per year (6-10). The 1943 introduction of penicillin for 52 pneumonia management was a medical triumph (11), but the intervening decades have 53 witnessed escalating age-adjusted pneumonia hospitalization rates (12-14) without survival rate 54 improvements of corresponding magnitude (15) . In an effort to address the persisting threat of 55 pneumonia to vulnerable populations, our laboratory has developed a program focused on 56 manipulating the intrinsic antimicrobial capacity of the host to prevent pneumonia.
58
Based on this program, we have reported that the mucosal defenses of the lungs can be 59 stimulated to protect mice against a wide array of otherwise lethal pneumonias, including those 60 caused by antibiotic-resistant bacteria (16) (17) (18) (19) . This inducible resistance is achieved following a 61 single inhaled treatment comprised of a synergistic combination of Toll-like receptor (TLR) 
87
1A) is associated with reduced bacterial burden immediately after infection, whether culturing 88 lung homogenates or bronchoalveolar lavage (BAL) fluid ( Figure 1B ), suggesting that a Pam2-
89
ODN-induced antimicrobial environment existed at the time of infection. No significant 90 differences were noted in the performance of the two culture methods, in terms of precision or 91 magnitude of induced bacterial reductions by Pam2-ODN, though the absolute bacteria per ml 92 tended to be higher in the BAL-obtained samples than in the lung homogenates. Proportionally 93 similar inducible reductions in pathogen burden were observed both immediately after infection 94 and 24 h after infection when mice were infected with fluorescent P. aeruginosa, then their lungs 95 were examined by fluorescence microscopy ( Figure S1 ). 
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ODN is administered in a fixed 4:1 molar ratio (18, 20) . Figure 2A antibacterial responses seemed to be achieved with six or more hours of treatment, but 138 significant bacterial burden reductions were achieved in a much shorter period ( Figure 2C -D) in 139 both mouse and human cells. In fact, the antibacterial effect was even observed when Pam2-
140
ODN is administered simultaneous to the infectious challenge. and there is no reason to suspect that induction of alternate species is reflected by the carboxy-
208
H 2 DCFDA signal in the current studies using identical culture and treatment models. influenza burden. Figure 3G shows that knocking down DUOX1 moderately impairs the Pam2- we could reduce inducible mitochondrial ROS production, rather than scavenging produced 259 ROS. Figure 4C shows that combination treatment with a mitochondrial complex II inhibitor and 260 a respiratory chain uncoupler reduces mitochondrial ROS production at every tested dose of 306 different peptide combinations may be required to protect against different challenges. So, we 307 might eventually recategorize certain peptides that we have previously deemed to be non-essential for protection as required for protection against specific (as yet untested) alternate 309 pathogens.
311
Regardless of explanation, the inability to detect any essential antimicrobial peptides, however, 312 serves to underscore the robustness of the Pam2-ODN-induced protection against otherwise 313 lethal pneumonias and profoundly emphasize the importance of our recent finding that epithelial 314 ROS production is required for inducible antiviral defense. Unlike the peptide studies, we have 315 clearly established that inducible ROS are essential to protecting against in vivo and in vitro 316 challenges by orthomyxoviruses and paramyxoviruses (23). The present study similarly finds 317 that inducible ROS production is essential to Pam2-ODN-induced epithelial bacterial killing.
318
Strikingly, we find that ROS derived from both DUOX-dependent and mitochondrial sources are 319 required for protection. 
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Weight loss is also among the approved indications for euthanasia, but the mice that met 442 euthanasia criteria in this model became ill or distressed within 1-2 d (before losing > 25% body 443 weight), so no mice were euthanized due to weight loss in the current study. Despite the close 444 observation, this same rapidity of illness resulted in up to 3 of the 56 infected mice dying 445 spontaneously from pneumonia before being euthanized in some experimental replicates.
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Although meeting euthanasia criteria is the primary endpoint, the presented "Survival (%)" in 
